Literature DB >> 27281847

[Dnmt2 is the Most Evolutionary Conserved and Enigmatic Cytosine DNA Methyltransferase in Eukaryotes].

V V Ashapkin, L I Kutueva, B F Vanyushin.   

Abstract

Dnmt2 is the most strongly conserved cytosine DNA methyltransferase in eukaryotes. It has been found in all organisms possessing methyltransferases of the Dnmt1 and Dnmt3 families, whereas in many others Dnmt2 is the sole cytosine DNA methyltransferase. The Dnmt2 molecule contains all conserved motifs of cytosine DNA methyltransferases. It forms 3D complexes with DNA very similar to those of bacterial DNA methyltransferases and performs cytosine methylation by a catalytic mechanism common to all cytosine DNA methyltransferases. Catalytic activity of the purified Dnmt2 with DNA substrates is very low and could hardly be detected in direct biochemical assays. Dnmt2 is the sole cytosine DNA methyltransferase in Drosophila and other dipteran insects. Its overexpression as a transgene leads to DNA hypermethylation in all sequence contexts and to an extended life span. On the contrary, a null-mutation of the Dnmt2 gene leads to a diminished life span, though no evident anomalies in development are observed. Dnmt2 is also the sole cytosine DNA methyltransferase in several protists. Similar to Drosophila these protists have a very low level of DNA methylation. Some limited genome compartments, such as transposable sequences, are probably the methylation targets in these organisms. Dnmt2 does not participate in genome methylation in mammals, but seems to be an RNA methyltransferase modifying the 38th cytosine residue in anticodon loop of certain tRNAs. This modification enhances stability of tRNAs, especially in stressful conditions. Dnmt2 is the only enzyme known to perform RNA methylation by a catalytic mechanism characteristic of DNA methyltransferases. The Dnmt2 activity has been shown in mice to be necessary for paramutation establishment, though the precise mechanisms of its participation in this form of epigenetic heredity are unknown. It seems likely, that either of the two Dnmt2 activities could become a predominant one during the evolution of different species. The high level of the Dnmt2 evolutionary conservation proves its activity to have a significant adaptive value in natural environment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27281847

Source DB:  PubMed          Journal:  Genetika        ISSN: 0016-6758


  7 in total

Review 1.  Uncovering epigenetic landscape: a new path for biomarkers identification and drug development.

Authors:  Daiane Teixeira de Oliveira; Renata Guerra-Sá
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

Review 2.  Epigenetics and bone diseases.

Authors:  Tu Huang; Xiu Peng; Zhenxia Li; Quan Zhou; Shishu Huang; Yuting Wang; Juan Li; Youqiang Song
Journal:  Genet Res (Camb)       Date:  2018-07-26       Impact factor: 1.588

Review 3.  Small extracellular vesicles in cancer.

Authors:  Komal Abhange; Amy Makler; Yi Wen; Natasha Ramnauth; Wenjun Mao; Waseem Asghar; Yuan Wan
Journal:  Bioact Mater       Date:  2021-04-07

4.  Circulating extracellular vesicle content reveals de novo DNA methyltransferase expression as a molecular method to predict septic shock.

Authors:  Duaa A Dakhlallah; Jon Wisler; Marieta Gencheva; Candice M Brown; Erin R Leatherman; Kanhaiya Singh; Kathy Brundage; Todd Karsies; Ahmad Dakhlallah; Kenneth W Witwer; Chandan K Sen; Timothy D Eubank; Clay B Marsh
Journal:  J Extracell Vesicles       Date:  2019-09-28

5.  Mouse Paternal RNAs Initiate a Pattern of Metabolic Disorders in a Line-Dependent Manner.

Authors:  Guzide Satir-Basaran; Leila Kianmehr; Ecmel Mehmetbeyoglu; Kezban Korkmaz Bayram; Mehmet Memis; Zeynep Yilmaz; Esra Tufan; Serpil Taheri; Fahrettin Kelestimur; Minoo Rassoulzadegan
Journal:  Front Genet       Date:  2022-03-28       Impact factor: 4.599

Review 6.  Emerging role of different DNA methyltransferases in the pathogenesis of cancer.

Authors:  Pengcheng Liu; Fan Yang; Lizhi Zhang; Ying Hu; Bangjie Chen; Jianpeng Wang; Lei Su; Mingyue Wu; Wenjian Chen
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

7.  Identification, expression, and artificial selection of silkworm epigenetic modification enzymes.

Authors:  Rui Gao; Chun-Lin Li; Xiao-Ling Tong; Min-Jin Han; Kun-Peng Lu; Shu-Bo Liang; Hai Hu; Yue Luan; Bi-Li Zhang; Yan-Yu Liu; Fang-Yin Dai
Journal:  BMC Genomics       Date:  2020-10-23       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.